baber/WOPTO huggingface dataset:
Patent NZ-523645-A (NZ)
Title: Polymeric michelle compositions
Inventor: LEROUX JEAN-CHRISTOPHE
IPC: A61K31/407
Filed: 2001-06-28
Abstract: A micelle-forming composition comprising: a hydrophobic core surrounded by a hydrophilic shell, wherein the shell is poly(N-vinyl-2-pyrroidone); and a therapeutic agent, preferably an antitumor agent selected from at least on phthalocyanine compound, anthracycline compound, antimetabolite, alkylating agent or taxane, wherein the agent is physically entrapped within the micelle; and the use of the composition for the manufacture of a medicament for administering a therapeutic agent to a subject in need thereof.
Patent NZ-524400-A (NZ)
Title: Process for selectively extracting bioactive components
Inventor: LANG TIMOTHY RALSTON
IPC: A23L33/105
Filed: 2001-09-04
Abstract: A process for selectively extracting bioactive components from a raw material extract derived from vegetable matter comprises: (a) passing the raw material extract through a passageway containing an adsorbent whereby at least some of the components to be extracted are adsorbed on to the adsorbent; (b) subsequently passing through the passageway an eluent mixture substantially containing water and alcohol whereby the concentration of alcohol in the eluent is increased at a substantially constant rate from 15 vol percent to 95 vol percent during at least those periods when the components are being eluted and (c) sequentially collecting an eluate in fractions corresponding to the presence of the extracted components. A process for selectively extracting bioactive components from a raw material extract derived from vegetable matter comprises: (a) combining the raw material extract with sufficient alcohol to ensure at least one bioactive component will not be adsorbed when the combined raw material and alcohol are passed through a first passageway containing adsorbent; (b) passing the combined raw material extract and alcohol through a first passageway containing an adsorbent whereby at least some of the components to be extracted are adsorbed on to the adsorbent; (c) reducing the alcohol component of the combined raw material extract and alcohol to less than 15 vol percent; (d) passing the combined raw material extract and remaining alcohol through a second passageway containing an adsorbent whereby remaining components to be extracted are adsorbed on to the adsorbent; (e) subsequently passing through the first passageway an eluent mixture substantially containing water and alcohol wherein the concentration of alcohol in the eluent is increased at a substantially constant rate from 50 vol percent to 95 vol percent during at least those periods when the components are being eluted. (f) subsequently passing through the second passageway an eluent mixture substantially containing water and alcohol wherein the concentration of alcohol in the eluent is increased at a substantially constant rate from 15 vol percent to 35 vol percent during at least those periods when the components are being eluted and (g) sequentially collecting from each passageway an eluent in fractions corresponding to the presence of the bioactive components. The adsorbent can be polystyrene-divinyl benzene and the alcohol can be ethanol. The vegetable matter can be citrus fruit, sugar cane, apples, potatoes, or a mixture of apples and potatoes or grapes and the bioactive components can be limomoid glucosides, flavanones, polymethoxylatedflavones, arephenolic acids, hydroxyflavones, phenolic acids, proanthocyanidins, adroxyflavones, stilbenes, proanthocyanidins, phenolic acids and/or anthocyanins.
Patent NZ-529754-A (NZ)
Title: Oxazol/ thiazol-derivatives activators of the hPPAR- alpha receptor
Inventor: GELLIBERT FRANCOISE JEANNE
IPC: A61K31/426
Filed: 2002-05-29
Abstract: Activators of the hPPAR receptor comprise the compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof, wherein: X1 represents O; R1 and R2 are methyl; R3 and R4 independently represent H, halogen, -CH3 and -OCH3; R5 represents H; X2 represents NH; Z is N, and Y is S; R6 represents phenyl and is optionally substituted by one or more halogen, CF3, C1-6 straight or branched alkyl (optionally substituted by halogen). Also disclosed is the use of the compound in therapy and a pharmaceutical composition comprising the compound for the manufacture of a medicament for the treatment of an hPPAR alpha disease or condition such as dyslipidemia, syndrome X, heart failure, hypocholesteremia, cardiovascular disease, type II diabetes mellitus, type I diabetes, insulin resistance, hyperlipidemia, obesity, anorexia bulimia and anorexia nervosa.
Patent NZ-529910-A (NZ)
Title: Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor
Inventor: MAUPIN-FURLOW JULIE A
IPC: C07H21/04
Filed: 2002-04-29
Abstract: Disclosed are isolated nucleic acids molecules which encode polypeptides capable of decarboxylating pyruvate into acetaldehyde. Also disclosed are recombinant expression vectors containing such nucleic acid molecules, recombinant host cells comprising the expression vectors, host cells further comprising other ethanologenix enzymes, and methods for producing useful substances, e.g., acetaldehyde and ethanol, using such host cells.
Patent NZ-535562-A (NZ)
Title: Method for detecting leptin receptor ligands using the energy transfer between fusion proteins composed of leptin receptors and of energy-donor or energy-acceptor proteins.
Inventor: COUTURIER CYRIL
IPC: C07K19/00
Filed: 2003-02-25
Abstract: Disclosed is a method for detection of leptin receptor ligands as a function of the transfer of energy between fusion proteins comprising leptin receptors and energy-donor and -acceptor proteins. Disclosed further are fusion proteins for application in said method.
Patent NZ-539620-A (NZ)
Title: A process for stabilizing an aroma-providing component against loss or degradation of desirable flavour during storage
Inventor: ZHENG YING
IPC: A23L27/28
Filed: 2003-09-26
Abstract: A process for stabilizing a aroma-providing component such as coffee aroma against loss or degradation of its flavor or sensory characteristics by associating the aroma-providing component with a stabilizing agent in an amount effective to reduce or prevent the loss or degradation of the flavor or sensory characteristics of the component and form a stabilized aroma-providing component followed by removing the stabilizing agent from the stabilized aroma prior to packaging for storage or prior to adding the stabilized aroma to a food or beverage product. The resulting stabilized aroma-providing component is essentially free of the stabilizing agent and may be incorporated into a food or beverage product with the initial flavor or sensory characteristics of the stabilized component being retained for a time period of at least two months during storage of the food or beverage product.
Patent NZ-541361-A (NZ)
Title: Neisseria meningitidis antigens and compositions relating to SEQ ID Nos:2916, 2918 and 2920
Inventor: FRASER CLAIRE
IPC: A61P31/04
Filed: 1999-04-30
Abstract: Disclosed is an isolated protein comprising an amino acid sequence selected from the group consisting of SEQ ID Nos:2916, 2918 and 2920. Also disclosed is an antibody which specifically binds to the protein and a nucleic acid which encodes the protein.
Patent NZ-542258-A (NZ)
Title: A medical composition comprising honey or sugar syrup and a viscosity increasing agent for use on wounds
Inventor: MOLAN PETER CHARLES
IPC: A23L21/25
Filed: 2005-09-06
Abstract: Disclosed is a paste for application to a wound comprising: honey or sugar syrup; and at least one viscosity increasing agent selected from guar gum, a methylcellulose compound, a hydroxyl ethyl cellulose compound, and combinations thereof; wherein the viscosity increasing agent or agents and honey or sugar syrup are mixed together at a ratio of approximately 0.75 to 2 parts viscosity increasing agent to 5 parts honey or sugar syrup; and, wherein the paste flows once mixed and attains an increased viscosity forming a semi-solid gel or solid on application to a moist wound environment. Also disclosed is a method for producing the above paste, and its use in treating wounds.
Patent NZ-544254-A (NZ)
Title: Methods and apparatus for conditioning and degassing liquids and gases in suspension
Inventor: HADFIELD DAVID
Filed: 2005-12-19
Abstract: Methods and apparatus for conditioning mixtures of gas and liquids by agglomerating gas bubbles existing with or in a liquid, or for coalescing droplets of liquid dispersed in another liquid are disclosed. The apparatus includes an ultrasonic transducer (4) arranged to impart vibrational energy to a liquid mixture or liquid/gas mixture and a reflector (6) located opposite the transducer. At least on baffle (12) extends between the transducer and reflector to divide the space into separate volumes. The baffles are rigid and prevent fluid flow passing between volumes.
Patent NZ-544283-A (NZ)
Title: Lift cage with cage electrical system integrated in the cage roof and method of mounting a lift installation
Inventor: ROSSIGNOL ERIC
IPC: B66B11/02
Filed: 2004-03-31
Abstract: The cabin electrics (8), necessary on the cabin (3), such as cabin computer, connections, communication devices etc, are integrated in an equipment chamber (7a), itself integrated in the cabin roof (7). The equipment chamber (7a) is arranged along an edge (7s) of the cabin roof. The height (h) used for cabin reinforcement is correspondingly made use of. The cabin electrics (8) are accessible for servicing purposes by means of a pivoting lid. The lid (9) also forms a standing surface for service of the shaft, when in the closed position.
Patent NZ-555909-A (NZ)
Title: Compositions and methods for reducing the degradation of phenylephrine by oxygen
Inventor: NICHOLS WILLIAM MICHAEL
IPC: A61K9/28
Filed: 2005-12-01
Abstract: Disclosed is a stable pharmaceutical composition comprising phenylephrine in a pharmaceutically effective amount and silicified microcrystalline cellulose in an amount effective to reduce the degradation of phenylephrine caused by oxygen.
Patent NZ-565927-A (NZ)
Title: Dimensional control of concrete blocks
Inventor: JOHNSON PAUL JOSEPH
IPC: B28B7/24
Filed: 2006-07-25
Abstract: A process for manufacturing concrete wall blocks front face up, the wall blocks, with respect to orientation in a wall, having the front face moulded with a predetermined three-dimensional pattern, an opposite rear face, top and bottom opposite faces extending between the front and rear faces, and side faces extending between the front and rear faces and the top and bottom faces, the process comprising the steps of: moulding a concrete wall block by depositing a dry cast concrete mixture into a mould 20, the mould 20 being positioned upright and having two parallel mould sidewalls 22 and two mould end walls 24 perpendicular to the two mould sidewalls 22, the upright mould 20 having an open top and an open bottom, the upright mould 20 being positioned on a pallet so that the open bottom is closed by the pallet; forming the concrete wall block side faces by compacting the dry cast concrete mixture against the mould sidewalls 22; forming the concrete wall block rear face by compacting the dry cast concrete mixture against the pallet; forming one or the concrete wall block top or bottom face by compacting the dry cast concrete mixture against a face region of a first division plate 26 that is rigidly constrained during operation of the process, the division plate 26 having side edges; the side edges of the first division plate 26 being rigidly constrained within a channel in each of the mould sidewalls 22, the channels being parallel to each other and generally perpendicular to the open top and open bottom of the mould 20; the first division plate 26 being rigidly constrained by securing each of the side edges to each of the mould sidewalls 22 at a plurality of separate locations by a bolt at each of the plurality of separate locations, each bolt extending through a mould sidewall and being threaded into a side edge of the first division plate 26; forming the other top or bottom face of the concrete wall block by compacting the dry cast concrete mixture against a face region of a wall or plate that is opposite to the first division plate 26; forming the concrete wall block front face by compacting the dry cast concrete mixture with a stripper shoe in the open top of the mould 20 to impart a predetermined three dimensional pattern to the concrete wall block front face, the predetermined three-dimensional pattern having a relief of at least about 0.5 inch; stripping the concrete wall block from the open bottom of the mould 20 onto the pallet; and curing the concrete wall block to result in a cured concrete wall block.
Patent NZ-574361-A (NZ)
Title: Transmucosal delivery devices with enhanced uptake containing buprenorphine
Inventor: VASISHT NIRAJ
IPC: A61K9/00
Filed: 2007-07-23
Abstract: Disclosed is a mucoadhesive delivery device suitable for transrnucosal administration of an effective amount of a buprenorphine compound to a subject, the mucoadhesive device comprising: a buprenorphine compound of the formula disclosed herein or pharmaceutically acceptable salts or esters thereof disposed in a mucoadhesive polymeric diffusion environment which has a pH between 4 and 7.5; wherein, R3 is selected from -C1-4 alkyl group or a cycloalkyl-substituted-C1-4 alkyl group; R4 is selected from - C1-4 alkyl; R5 is -OH or taken together, R4 and R5 form a =O group; and R6 is selected from -H or a - C1-4 alkyl group a barrier layer disposed relative to the mucoadhesive polymeric diffusion environment such that a unidirectional gradient is created upon application of the device to a mucosal surface.
Patent NZ-577700-A (NZ)
Title: Wind power generator including a wind tunnel fed from a tower
Inventor: SATO SHIGERU
IPC: F03D11/04
Filed: 2007-12-18
Abstract: Disclosed is a wind power apparatus which can make effective use of the energy of a weak wind irrespectively of the wind direction thereby to generate electric power. The wind power apparatus comprises a wind tunnel (30) constituted of a cylindrical member erected vertically from a foundation, a plurality of wind-collecting plates (15) extending in the direction of the normal to the circumferential wall of the cylindrical member, a plurality of vertical guide plates disposed between the wind-collecting plates, a plurality of wind inlets for introducing the wind collected by the wind-collecting plates, into the wind tunnel, back-flow preventing means for allowing only the flow of the wind from the outside of the cylindrical member to the inside of the cylindrical member, a turbine to be driven by the wind blown from one end portion of the wind tunnel, and a power generator to be driven by the turbine.
Patent NZ-578378-A (NZ)
Title: Benzofuran antiparasitic agents
Inventor: GIBSON STEPHEN PAUL
IPC: A01N43/08
Filed: 2008-02-08
Abstract: A compound of the formula (I) e.g. N-[1-cyano-1-(5-cyano-2,3-dihydro-1-benzofuran-2-yl)ethyl]-4-[(trifluoromethyl)thio]benzamideor a tautomer thereof, or a pharmaceutically acceptable salt of said compound, tautomer, wherein: X is O or S and the other substituents are defined in the specification. Further disclosed is the use of the compound of formula (I) in the preparation of a medicament for the treatment of a parasitic infestation in a host animal, and a method of treatment of a parasitic infestation in a host animal, wherein the host animal is a non-human animal. Also disclosed is a pharmaceutical composition comprising a compound of formula (I).
Patent NZ-580550-A (NZ)
Title: Biofertilizer formulation
Inventor: GIDEKEL MANUEL
IPC: C12N1/20
Filed: 2008-04-21
Abstract: Provided is a biofertilizer composition, comprising psychrophilic bacterial strains isolated from rhizosphere of Deschampsia antarctica, wherein the composition contains one or more bacterial strains selected from the group consisting of Pseudomonas antarctica DaBact TI-8 (PTA 8990), Pseudomonas trivialis DaBact 2H (PTA 8988) and Arthrobacter ssp. DaBact MII-9 (PTA 8989).
Patent NZ-582315-A (NZ)
Title: Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
Inventor: UMANA PABLO
IPC: A61K38/00
Filed: 2004-01-22
Abstract: Disclosed is an isolated yeast or mammalian host cell engineered to express at least one nucleic acid encoding a fusion polypeptide having beta(1,4)-N-acetylglucosaminyltransferase III activity or beta(1,4)-galactosyltransferase activity in an amount sufficient to modify the oligosaccharides in the Fc region of a polypeptide produced by said host cell, wherein said polypeptide is selected from the group consisting of a whole antibody molecule, an antibody fragment, and a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin. Reference has been directed, in pursuance of section 16(1) of the Patents Act 1953, to patent No. 567321. (62) Divided Out of 567321
Patent NZ-584580-A (NZ)
Title: Permanent magnet motor with operably decouplable first and second rotors
Inventor: HOCHHALTER KEITH
IPC: H02K1/22
Filed: 2008-09-11
Abstract: A permanent magnet, brushless motor comprising a primary rotor (22) having alternating magnetic poles around a circumference, a secondary rotor (20) similar to the primary rotor. The primary rotor may be free to rotate by approximately plus or minus one pole of the secondary rotor. As such, when the two rotor components have opposite polarities aligned, the motor may be in a field weakened state. Generally, the field weakened state may be the normal state of the motor. As a significant load is encountered, the rotors may automatically transition to a non-weakened state wherein similar polarities are aligned on the rotors. A permanent magnet, brushless motor as described herein may be employed at a motor level or integrated into a linear actuator, wherein the rotor of the permanent magnet, brushless motor may include a hollow shaft.
Patent NZ-585408-A (NZ)
Title: Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis
Inventor: TAM YUN KAU
IPC: A23L33/00
Filed: 2009-01-28
Abstract: Disclosed is a composition comprising an initial composition of at least 22.75 percent calcium by weight extracted from calcium containing or synthetic calcium acetate containing sources (such as pearls, corals, oysters, or natural mines), wherein said initial composition is fortified with magnesium and zinc to provide a final composition of at least 4 percent by weight of calcium, at least 5 percent by weight of magnesium, at least 0.2 percent by weight of zinc, and at least 400 IU of vitamin D3, wherein the composition comprises more bioavailable calcium per unit weight than calcium carbonate; wherein the composition is for use in the alleviation or prevention of osteoporosis, for use to increase bone density, or for the facilitation of absorption of dietary calcium and magnesium.
Patent NZ-586938-A (NZ)
Title: Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
Inventor: DUBOIS LAURENT
IPC: A61K31/437
Filed: 2009-01-20
Abstract: The disclosure relates azabicyclic carboxamide compounds of formula (I), in the form of a base or of an addition salt with an acid, and also in the form of a hydrate or of a solvate, wherein the variables shown in formula (I) are as defined in the specification. The disclosure also relates a process for the preparation of these compounds as well as compositions comprising such compounds and therapeutic methods that utilize such compounds. These compounds are suitable for treating pathologies in which receptors of TRPV1 type are involved and can be used for treating pain, inflammation, metabolic disorders, urological disorders, gynaecological disorders, gastrointestinal disorders, respiratory disorders, psoriasis, pruritus, dermal, ocular or mucous irritations, herpes, zona, multiple sclerosis, depression and cancers.
Patent NZ-588104-A (NZ)
Title: Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
Inventor: MULLER GEORGE W
IPC: A61K31/4035
Filed: 2008-03-27
Abstract: The disclosure relates to solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2- methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione represented by structural formula (I), compositions comprising the solid forms, methods of making the solid forms and methods of their use are disclosed. These solid forms are suitable for treating and/or preventing disorders ameliorated by the reduction of levels of TNF-a or the inhibition of PDE4.
Patent NZ-589018-A (NZ)
Title: Synergistic active ingredient combinations
Inventor: JESCHKE PETER
IPC: A01N37/40
Filed: 2009-04-28
Abstract: Disclosed is a combination comprising the compound of formula (I), wherein Y is a thiazole or a pyridine moiety, and the rest of the substituents are defined within the specification, and another active compound selected from acetylcholinesterase inhibitors, antagonists of GABA-gated chloride channels, sodium channel modulators/blockers of voltage-gated sodium channels, agonists/antagonists of the nicotinergic acetylcholine receptor, allosteric modulators of the acetylcholine receptor, juvenile hormone analogues, site II and site III electron transport inhibitors or other compounds as defined in the specification. Also disclosed is the use of the above mentioned combination for controlling pests.
Patent NZ-589617-A (NZ)
Title: 3-(Inden-4-yl)-5-(phenyl)-1,2,4-oxadiazole and 3-(tetralin-5-yl)-5-(phenyl)-1,2,4-oxadiazole derivatives
Inventor: ROBERTS EDWARD
IPC: A61K31/41
Filed: 2009-05-14
Abstract: Disclosed are compounds of general formula (I), which are derivatives of 3-(inden-4-yl)-5-(phenyl)-1,2,4-oxadiazole and 3-(tetralin-5-yl)-5-(phenyl)-1,2,4-oxadiazole; wherein: a dashed line signifies that a single bond or a double bond can be present, provided that there are two double bonds and three single bonds in the ring comprising A1, A2, and A3; A1, A2 and A3 each independently are C, O, N, NH or N(alkyl), provided that no more than one of A1, A2 or A3 are C, at least one of A1, A2 or A3 is a nitrogen atom, and provided that only one of A1, A2 or A3 is O; L1 and L2 are each a bond; R5 is a bicyclic indan-4-yl or tetralin-5-yl ring moiety which is substituted with 0-5 J; R6 is phenyl ring which is substituted with one or more J; and wherein the remaining substituents are as defined herein. Further disclosed is a pharmaceutical composition which comprises a compound as defined above, for the treatment of multiple sclerosis, transplant rejection, or adult respiratory distress syndrome.
Patent NZ-594727-A (NZ)
Title: Shredder hammers including improved engagement between the hammer pin and the hammer
Inventor: HOICE JOHN P
IPC: B02C13/00
Filed: 2010-02-26
Abstract: 594727 Disclosed is a shredder hammer with design details on the hammer openings for the retaining pins to provide an increased service life. The shedder hammer includes a hammer pin opening in which at least some portion of the interior surface is convex curved in a direction moving from one major surface of the shredder hammer to the other. This interior surface may be smoothly formed as an arc of a circle, as a parabola, as a hyperbola, or as another curved surface, with the local extrema within the interior of the hole (e.g., at or near the center). Providing the curved interior surface helps vary and disperse the locations where force is absorbed due to contact between the hammer pin and the walls defining the hammer pin opening when the shredding hammer blade contacts the material to be shredded. Other structures include engagement between the hammer pin and the hammer as part of a bushing member, a spool or sleeve member, or a ball swivel member.